Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 401–500 of 805
Wang, Z., Wang, J., He, L., Jiang, C., Wang, Y., Shen, T., Zhao, M., Li, E., Zhou, N., Sang, C., et al. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70095 · Cited by 3
Li, N., Yang, Z., Yuan, Q., & Cheng, W.-L. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70098 · Cited by 3
Cheon, D. Y., Han, K., Lee, Y. J., Lee, J. H., Park, M. S., Lee, S. J., Han, S., Choi, J.-H., & Lee, M. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf573 · Cited by 5
Intensive blood pressure control benefits older patients
Fernández-Ruíz, I. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00626-0 · Cited by 3
Glycemic status and the association of change in blood pressure with incident cardiovascular disease
Suzuki, Y., Kaneko, H., Yano, Y., Okada, A., Itoh, H., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.07.005 · Cited by 3
Bahat, G., Özkök, S., & Petrović, M. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00984-5 · Cited by 3
Mokwena, K. E., & Modutoane, M. B. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_740_22 · Cited by 3
A Protocol for Developing Chinese Clinical Practice Guidelines of Hypertension
Lou, Y., Ma, W., Wang, Z., Yang, N., Sun, Y., Liu, Y., Lei, R., Zhao, J., Luo, X., Wang, L., et al. (2022) · Cardiology Discovery · doi:10.1097/cd9.0000000000000078 · Cited by 3
Self-citationZhang, S., Cui, Y.-L., Yu, S., Shang, W., Li, J., Pan, X., Wen, Z., Huang, S., Chen, L., Shen, X., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041556 · Cited by 3
Self-citationYu, Y., Wang, P., Ren, Z., Xue, Y., Jia, Y., Wang, W., Liu, M., Pan, K., Xiao, L., Ji, D., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114484 · Cited by 3
Armas-Padrón, A. M., Sicilia-Sosvilla, M., Esteban, P. R., Torres, A., & Hernández, D. (2023) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2023.04.004 · Cited by 4
Recent evidence on target blood pressure in patients with hypertension
Kim, H. (2024) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2024.6.e3 · Cited by 3
Cumulative blood pressure load and hypertensive nephropathy in Han Chinese hypertensive patients
Liu, K.-W., Hung, M., Huang, C., & Chen, J. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14776 · Cited by 3
Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trial
Zhao, S., Deng, Y., Wang, Y., Yu, S., Han, J. S., Cai, J., & Zhang, Y. (2024) · Nature Aging · doi:10.1038/s43587-024-00591-6 · Cited by 3
Self-citationTolerability of Antihypertensive Medications: The Influence of Age
Rivasi, G., Coscarelli, A., Capacci, M., Ceolin, L., Turrin, G., Tortù, V., D’Andria, M., Testa, G. D., & Ungar, A. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00639-z · Cited by 3
Optimal Blood Pressure Targets with Age
Supiano, M. A. (2024) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2024.04.002 · Cited by 3
Li, H., He, Q., Wenqing, Z., Yanjun, Z., Wangjia, P., Yu, S., Zhuoga, D., Zhang, Y., & Zhao, Y. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15232 · Cited by 3
Yang, H., Huang, C., Sawano, M., Herrin, J. S., Chen, G., Li, Z., Spatz, E. S., Krumholz, H. M., & Lu, Y. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.01.033 · Cited by 3
Chen, X., Wang, L., Jiang, Y., Tang, W., Xiao, J., Deng, W., Ren, X., & Li, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1508667 · Cited by 4
Self-citationThe Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy
Wang, J., Li, W., Gui, M., Liu, Y., Wang, S., Wu, S., & Huang, W. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf141 · Cited by 4
Self-citationDasa, O., Smith, S. M., & Pepine, C. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00033-5 · Cited by 4
Hypertension in older patients: a STEP forward?
Bénétos, A., Persu, A., & Kreutz, R. H. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2075826 · Cited by 3
Navigating the 2024 ESC Hypertension Guidelines
Lu, Y., Spatz, E. S., & Krumholz, H. M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.114 · Cited by 3
Zhang, Z., Liu, Y., Li, Y., Geng, T., Chen, S., Wu, S., & Gao, X. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04237 · Cited by 2
Self-citationKoller, Á., Járai, Z., & Takács, J. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000003985 · Cited by 4
Zuo, W., Huang, Y., Sun, Z., Yang, Y., Zhang, J., Zhang, X., & Yao, K. (2025) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000069 · Cited by 2
Fallahtafti, P., Semirani-Nezhad, D., Maleki, S., Zafarmandi, S., Dastjerdi, P., Rahmati, S., Roozbehi, K., Shaker, F., Fekri, M., Nanna, M. G., et al. (2025) · American Journal of Nephrology · doi:10.1159/000547812 · Cited by 2
Chronic kidney disease for the primary care provider
Doak, W., Lerma, E. V., & Shah, A. D. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102027 · Cited by 2
Mo, C., Li, X., Wang, S., Wang, J., He, L., Peng, R., Zheng, J., Liang, F., & Gu, D. (2025) · Journal of Global Health · doi:10.7189/jogh.15.04321 · Cited by 3
European Hypertension Guidelines: Similarities and What the Practicing Physician Should Keep in Mind
Zeniodi, M. E., Τσαγανός, Θ., Menti, A., Komnianou, A., Κόλλιας, Α., & Stambolliu, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020859 · Cited by 4
Wang, S., Wang, J., Wang, Y., Xu, X., Gu, H., Xie, W., Ly, C., Zhang, J., Wang, T., Zhao, Z., et al. (2026) · Age and Ageing · doi:10.1093/ageing/afag005 · Cited by 2
Self-citationGuo, X., Zhou, S., Mu, J., Zhao, C., Sun, G., Zhou, Y., Yu, Y., Tan, X., Yin, Y., Xie, Z., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.57180 · Cited by 3
Self-citationJoshi, P., Rick, G., Mesineni, S., Bohara, S., Atif, S., Poonthottam, N., Azam, A., Mehmood, Y., Ali, R., Raquib, N., et al. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00268-y · Cited by 3
Kim, D. Y., Kim, S. H., Han, S. W., Ok, J. S., Son, J., Jeong, J. O., Kim, E. J., Choi, S., Jung, I. H., Ryu, S. K., et al. (2026) · Clinical Hypertension · doi:10.5646/ch.2026.32.e11 · Cited by 2
Real-World Adoption of the 2021 KDIGO BP Guideline in CKD
Lee, H., Cho, S. M. J., McCarthy, C. P., Yoo, T., Wadhera, R. K., Secemsky, E. A., & Natarajan, P. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001046 · Cited by 2
Arshad, M. S., Saad, M., Lurz, P. C., Rommel, K., Khan, M., Bangalore, S., Aronow, H. D., Swaminathan, R. V., Gutiérrez, J. A., & Fudim, M. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10600-y · Cited by 2
Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT
Pewowaruk, R. J., Jaeger, B. C., Hughes, T. M., Upadhya, B., Kitzman, D. W., Supiano, M. A., & Gepner, A. D. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102734 · Cited by 2
Xiong, C., Qiu, W., Zeng, K., Tang, M., Gao, Z., & Li, L. (2026) · Clinical Hypertension · doi:10.5646/ch.2026.32.e23 · Cited by 1
Iwasa, K., Omori, N., Aritake, S., Aoki, Y., Kanai, Y., & Nagai, A. (2026) · Hypertension Research · doi:10.1038/s41440-026-02639-z · Cited by 3
Cheng, H., Yeh, C., Wu, C., Chen, M. Y., Chang, Y., Tsai, H.-H., Chen, Z.-W., Lee, H.-C., Pan, H., Hsu, R.-Y., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.09.040 · Cited by 2
Self-citationCardiovascular Epidemiological Research in China: A Wake-up Call No One Can Afford to Ignore
Wei, X., Jiang, D., & Wan, S. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100308 · Cited by 2
Salvador, V. D., & Bakris, G. L. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100079 · Cited by 2
“As we grapple with the dilemma regarding the risk/benefit ratio between intensive and standard BP goals, the recently published STEP trial by Zhang and colleagues [4] helps to close this gap.”
BackgroundInfluentialWhelton, P. K., Bundy, J. D., & Carey, R. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac045 · Cited by 2
Top studies of 2021 relevant to primary care: From the PEER team
Moe, S. S., Perry, D., Thomas, B., Nickonchuk, T., Braschi, É., Dugré, N., Finley, C. R., Lindblad, A. J., Potter, J., & Allan, G. M. (2022) · Canadian Family Physician · doi:10.46747/cfp.6805329 · Cited by 2
Integrated hypertension management and national hypertension discipline promotion in China
Fan, L., & Cai, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002020 · Cited by 2
Self-citationBui, A. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2022.05.005 · Cited by 2
Bonifant, G. C., & Weir, M. R. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac313 · Cited by 3
Giulio, P. (2022) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000188 · Cited by 4
Liu, Y., Chen, S., Lee, W.-H., Chen, Y., Hsu, P., Tsai, W., Lee, C., Lin, T., Hung, C., Kuo, C., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416525 · Cited by 2
Self-citationIntensive blood pressure control in older patients with hypertension—a STEP in the right direction?
Liang, X., Chou, O. H. I., & Cheung, B. M. Y. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad011 · Cited by 2
Takeuchi, M., Shinkawa, K., Yanagita, M., & Kawakami, K. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02341-1 · Cited by 3
Optimal target blood pressure in older patients with hypertension
Kim, K. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e4 · Cited by 3
The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
Li, Y., Zhang, Y., Xiao, K., Jin, S., Zhang, H., Sun, L., Miao, Z., Zhao, T. S., Sun, J., Sun, X., et al. (2023) · Clinical Cardiology · doi:10.1002/clc.24087 · Cited by 2
Self-citationFeng, X., Yan, M., Tang, L.-H., Zhou, D., Wu, S., Cai, J., & Feng, Y. (2023) · Clinical Cardiology · doi:10.1002/clc.24172 · Cited by 2
Self-citationHow can we increase the efficacy of antihypertensive treatment?
Özyüncü, N., & Erol, Ç. (2024) · Kardiologia Polska · doi:10.33963/v.kp.98705 · Cited by 5
Qin, L., Wu, X., Tan, C., Zhang, Z., Li, Y., Zhu, X., Qin, S., & Tan, S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1325947 · Cited by 2
“Previous studies showed that intensive blood pressure control ( 120/80 mmHg) could reduce the risk of cardiovascular events (46, 47).”
BackgroundSelf-citationOvercoming Clinical Inertia in the Treatment of Hypertension
Arakawa, K., Imazu, R., Morinaga, Y., Tominaga, M., & Tsuchihashi, T. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3747-24 · Cited by 2
Is Intensive Blood Pressure Control Indicated in Older Patients with Hypertension?
Htay, T., Lane, M., Khanjani, N., Mianroodi, A. A., & Ream-Winnick, S. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02080-z · Cited by 2
Li, J., Bi, J., Yang, S., Wang, S., Yang, S., Chen, S., Han, K., Luo, S., Jiang, Q.-Y., Liu, M., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2507235 · Cited by 2
What Constitutes Adequate Control of High Blood Pressure? Current Considerations
Casey, D. E., Blood, A. J., Persell, S. D., Pohlman, D., & Williamson, J. D. (2024) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2024.06.001 · Cited by 3
General Principles, Etiologies, Evaluation, and Management in Older Adults
Egan, B. M., Rich, M. W., Sutherland, S. E., Wright, J. T., & Kjeldsen, S. E. (2024) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2024.04.008 · Cited by 2
Фанилевич, Г. И., Beylerli, O., Ilyasova, T., & Wang, C. (2024) · Current Hypertension Reviews · doi:10.2174/0115734021334958240903072642 · Cited by 2
Kenny, A. L., & McEvoy, J. W. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf018 · Cited by 2
Tian, X., Zhang, X., Chen, S., Xia, X., Xu, Q., Wang, Y., Wu, S., & Wang, A. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.012 · Cited by 3
Self-citationLin, R., Ling, Q., Wang, W., Li, W., Lin, Y., Chen, J., Tong, S., Cai, J., Li, J., & Chen, Y. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0690 · Cited by 2
Self-citationEschenhagen, T., & Weil, J. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_6 · Cited by 2
Li, S., Du, Z., Chen, H., Zhao, L., Zhou, P., Zhang, X., Anwar, S., Lv, J., Pan, Z., & Guo, X. (2025) · Postgraduate Medicine · doi:10.1080/00325481.2025.2502317 · Cited by 2
Almabruk, B. A., Alturki, L. S., Alghamdi, A. M., Almutairi, T., Alsulami, E. A., Alsharif, A. S., Saad, L., Alsaedi, S. A., Alkhoshiban, O. E., Alshareef, N. H., et al. (2025) · Cureus · doi:10.7759/cureus.94130 · Cited by 5
“management types [12,16,20,21,27,29] Finally, the overall compliance rate reported was 78.8% (95% CI: 69.2-88.4; I² = 100%).”
InfluentialWhat we learned from STEP that we didn't already know from SPRINT
Modesti, P. A. (2021) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2021.200116 · Cited by 2
Hypertension and Kidney Disease
Fadem, S. Z. (2022) · Springer eBooks · doi:10.1007/978-3-030-93528-3_5 · Cited by 2
Team-based strategies to prevent heart failure
Taha, M. B., Patel, K. V., & Nasir, K. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000959 · Cited by 2
Lin, B., Liu, X., Yao, S., & Pan, Z. (2023) · International Journal of Hypertension · doi:10.1155/2023/7533353 · Cited by 2
Balletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01043-2 · Cited by 4
“In einigen Studien war eine intensivierte Blutdrucktherapie mit einer niedrigen kardiovaskulären Ereignis-rate assoziiert [15, 16].”
BackgroundTao, F., Wang, W., Yang, H., Han, X., Wang, X., Dai, Y., Zhu, A., Han, Y., & Guo, P. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2406165 · Cited by 2
Association of baseline serum cholesterol with benefits of intensive blood pressure control
Wang, X., Feng, Y., Yang, L., Zhang, G., Tian, X., Ling, Q., Tan, J., & Cai, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002474 · Cited by 2
Self-citationPeng, K., Cai, W., Liu, X., Liu, Y., Ouyang, M., Gong, J., Wang, Z., Wang, Y., Hao, J., Wang, W., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074575 · Cited by 3
Heaton, J. N., Imburgio, S., Mararenko, A., Udongwo, N., Alshami, A., Schoenfeld, M. S., Apolito, R., Selan, J. C., Sealove, B. A., & Almendral, J. G. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23013 · Cited by 2
Improving outcomes for older hypertensive patients: is more intensive treatment better?
Deng, Y., Zhang, G., Wang, L., & Cai, J. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2034500 · Cited by 2
Self-citationLetter regarding “diagnosis and treatment of arterial hypertension 2021”
Ix, J. H., Tomson, C., Cheung, A. K., Mann, J. F. E., Cushman, W. C., Cheung, M., & Chang, T. I. (2022) · Kidney International · doi:10.1016/j.kint.2021.12.034 · Cited by 3
Preface—Special issue for hypertension in Asia: from the Okinawa declaration to the ISH 2022
Hoshide, S., Nishiyama, A., Mogi, M., & Kario, K. (2022) · Hypertension Research · doi:10.1038/s41440-022-00871-x · Cited by 2
Self-citationKario, K., Hoshide, S., & Mogi, M. (2022) · Hypertension Research · doi:10.1038/s41440-022-00915-2 · Cited by 2
Self-citationCan Artificial Intelligence Change the Practice of Managing Hypertension?
Kim, S.-E., & Lee, C. J. (2022) · Korean Circulation Journal · doi:10.4070/kcj.2022.0254 · Cited by 2
Importance of reconfirming the validity of the revised blood pressure categories
Asayama, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01206-0 · Cited by 2
Therapeutic Nihilism in Older Hypertensives: A Resounding Call to Action
Flack, J. M., & Cheema, A. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20091 · Cited by 2
Antihypertensive treatment targets in older adults: an unsolved dilemma
Rivasi, G., Matteucci, G., & Ungar, A. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad182 · Cited by 2
Antihypertensives in dementia: Good or bad for the brain?
Heutz, R. A. M., Weijs, R. W. J., de Heus, R. A. A., & Claassen, J. A. H. R. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231179421 · Cited by 2
Surveying the New Landscape of Blood Pressure Control
Murphy, G., & McEvoy, J. W. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02804 · Cited by 2
JSH2025 guidelines for hypertension management in older adults: international comparison
Yamamoto, K. (2026) · Hypertension Research · doi:10.1038/s41440-026-02550-7 · Cited by 2
Kario, K., Shibata, S., & Nishiyama, A. (2026) · Hypertension Research · doi:10.1038/s41440-026-02732-3 · Cited by 2
Self-citationPredictors for success of renal denervation in patients with resistant arterial hypertension
Orekhov, A. Y., Каражанова, Л. К., Chinybayeva, A., Жукушева, Ш. Т., & Конради, А. О. (2023) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2023-29-2-175-185 · Cited by 1
Santo, K., Sampaio, G., & Berwanger, O. B. (2023) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2023300122-7 · Cited by 32
Kardiovaskuläre Pharmakotherapie im Alter
Schulz, M., Trenk, D., & Laufs, U. (2023) · Herz · doi:10.1007/s00059-023-05191-5 · Cited by 1
Isolated Systolic Hypertension
Li, Y., & Staessen, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00018-9 · Cited by 1
Self-citationApproach to hypertension in geriatric population
Felek, D., & Çi̇fci̇, A. (2023) · Journal of Cardiology & Cardiovascular Surgery · doi:10.51271/jccvs-0013 · Cited by 1
Slow on the Draw—ED Management of Elevated BP in Older Adults
Eurick-Bering, K., Todd, B. R., & Cameron‐Comasco, L. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01284-y · Cited by 1
Implementation Research and Results of Hypertension Control Strategy and Model in Rural Areas
Sun, G., Wu, J., Zhang, P., Yu, Y., & Sun, Y. (2023) · Cardiology Discovery · doi:10.1097/cd9.0000000000000102 · Cited by 3
Self-citationDietary approach for the treatment of arterial hypertension in patients with diabetes mellitus
Barcellos, P. A. M., Dall’Agnol, A., Sandi, G. M., Remonti, L. R., & Silveiro, S. P. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003674 · Cited by 1
Zhong, Y., Feng, C., Hou, L., Yang, M., Zhang, X., Wu, J., Dong, B., Jia, P., Yang, S., & Dou, Q. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05094-y · Cited by 1
Treatment of hypertension in the elderly: target the lowest well-tolerated blood pressure
Angeli, F., Verdecchia, P., Mazzieri, A., & Reboldi, G. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2427637 · Cited by 1
McEvoy, J. W., McCarthy, C. P., Brouwers, S., & Others, A. (2025) · HYPERTENSION · doi:10.22141/2224-1485.17.4.2024.372 · Cited by 2
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.